Forbes March 26, 2025
Amy Feldman and Alex Knapp

In this week’s edition of InnovationRx, we look at the trend in fatal drug overdoses, 23andMe’s bankruptcy, the new CDC nominee, and more. To get it in your inbox, subscribe here.

Fatal drug overdoses, including from fentanyl, are falling.

The latest preliminary estimates from the Centers for Disease Control and Prevention show a 25% decline in overdose deaths for the 12 months ended in October 2024 versus the same period in 2023. That’s a huge drop— with decreases in the number of fatalities from fentanyl and other synthetic opioids leading the way.

Some 82,000 overdose deaths were reported for that period, which is still significantly higher than a decade ago. And some cities still have a major problem: In San...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Healthcare System, Insurance, Medicaid, Pharma / Biotech, Precision Medicine, Public Health / COVID
H.R.1 Threatens The Stability Of Medicaid Managed Care
How To Keep Competition Alive In Medicaid Managed Care Markets
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
Fortifying Medicaid Managed Care for Postpartum Enrollees: The Clearest Path to Improving Maternal Health
Medicaid and Upcoming State Budget Debates

Share Article